Secondary
Evofem Biosciences, Inc.
We are a clinical-stage biopharmaceutical company committed to developing and commercializing innovative products to address unmet needs in women’s sexual and reproductive health
Symbol
EVFM
Last Closing Price
$7.36
Anticipated Date
TBD
Underwriters
RBC Capital Markets, Cantor, Oppenheimer & Co., Roth Capital Markets
To view the prospectus for Evofem Biosciences, Inc., or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277